Inoviem Scientific offers a range of services tailored to the needs of drug discovery, preclinical and clinical development.
Understand the mode of action of your compound
Identify and validate targets
Choose your lead compound for development
Stratify different patient groups
Define the indication
Our expertise in translational pharmacology
Inoviem offers translational target discovery and drug-target Mode of Action (MoA) based on proprietary label-free technologies, developed in a pathological and physiological environment, that uses human tissue.
Translational pharmacology expertise
Pre-clinical to clinical phases
Our innovative approach
Biomarkers, patient and therapeutic window
Advantages of approach
Save time and money
How we work with clients
Tailored methodologies and technologies
Inoviem provides breakthrough protein technologies for each phase of the drug development process.
One of the major advantages of our label-free technologies used under physiological conditions and in human tissue – NPOT® and PIMS® – is that the test compound retains its original structure, as well as the exact same molecular structure that would be used in therapy
How to best identify the Mode of Action of your compound
From preclinical to clinical
Ensure Phase II study and success of your drug candidate in Phase III
Successfully identify the cohort of patients who will respond to your therapy
- About us
Inoviem, a bioanalytical Contract Research Organization (CRO), enables drug developers to gain greater precision in the understanding of a compound’s clinical Mode of Action (MoA), so that a drug candidate can move rapidly to clinical trials.
Our approach is based on the simple idea that current technologies fail to take into account the natural environment in which a drug will have its beneficial effect…
Inoviem Scientific’s core values are deeply ingrained in our past, present and future; they guide us in our daily work…
At Inoviem, we are committed to contributing work that upholds the quality of life and well-being of individuals…
- Management team
- Scientific board
- Supervisory board & investors
- Contact us